Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-01-10 3:53 pm Sale | 13G | AGM Group Holdings Inc. AGMH | SABBY MANAGEMENT LLC | 627,936 11% | -865,501![]() (-57.95%) | View |
2023-01-10 3:15 pm Sale | 13G | Cingulate Inc. CING | SABBY MANAGEMENT LLC | 564,340 11% | -321,914![]() (-36.32%) | View |
2023-01-10 2:47 pm Sale | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT LLC | 796,706 11% | -434,124![]() (-35.27%) | View |
2023-01-10 2:35 pm Sale | 13G | Tantech Holdings Ltd TANH | SABBY MANAGEMENT LLC | 41,500 11% | -6,146,297![]() (-99.33%) | View |
2023-01-10 2:21 pm Sale | 13G | HeartBeam, Inc. BEAT | SABBY MANAGEMENT LLC | 271,788 11% | -211,532![]() (-43.77%) | View |
2023-01-10 2:10 pm Sale | 13G | Recon Technology, Ltd. RCON | SABBY MANAGEMENT LLC | 1,482,066 11% | -1,211,639![]() (-44.98%) | View |
2023-01-10 1:49 pm Sale | 13G | Bit Digital, Inc. BTBT | SABBY MANAGEMENT LLC | 3,166,917 11% | -1,048,935![]() (-24.88%) | View |
2023-01-10 1:36 pm Purchase | 13G | Virpax Pharmaceuticals, Inc. VRPX | SABBY MANAGEMENT LLC | 988,165 11% | 111,331![]() (+12.70%) | View |
2023-01-10 11:57 am Purchase | 13G | PharmaCyte Biotech, Inc. PMCB | SABBY MANAGEMENT LLC | 934,456 11% | 673,528![]() (+258.13%) | View |
2023-01-10 11:40 am Sale | 13G | Cocrystal Pharma, Inc. COCP | SABBY MANAGEMENT LLC | 420,710 11% | -5,317,410![]() (-92.67%) | View |
2023-01-10 11:21 am Sale | 13G | Pulmatrix, Inc. PULM | SABBY MANAGEMENT LLC | 301,938 11% | -3,315,105![]() (-91.65%) | View |
2023-01-10 10:14 am Sale | 13G | Rebus Holdings, Inc. RBSH | SABBY MANAGEMENT LLC | 0 0% | -1,137,260![]() (Position Closed) | View |
2023-01-04 09:21 am Purchase | 13G | BiondVax Pharmaceuticals Ltd. BVXV | SABBY MANAGEMENT LLC | 228,329 11% | 228,329![]() (New Position) | View |
2023-01-04 09:09 am Purchase | 13G | RedHill Biopharma Ltd. RDHL | SABBY MANAGEMENT LLC | 7,540,400 11% | 7,540,400![]() (New Position) | View |
2023-01-04 09:01 am Purchase | 13G | TuanChe Limited TC | SABBY MANAGEMENT LLC | 2,384,713 11% | 2,384,713![]() (New Position) | View |
2023-01-04 08:49 am Purchase | 13G | Huadi International Group Co., Ltd. HUDI | SABBY MANAGEMENT LLC | 1,422,494 11% | 1,422,494![]() (New Position) | View |
2023-01-04 08:40 am Purchase | 13G | Kiromic BioPharma, Inc. KRBP | SABBY MANAGEMENT LLC | 1,822,847 11% | 1,822,847![]() (New Position) | View |
2023-01-04 08:33 am Purchase | 13G | Quanergy Systems Inc. QNGY | SABBY MANAGEMENT LLC | 936,905 11% | 936,905![]() (New Position) | View |
2023-01-04 08:25 am Purchase | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 264,000 11% | 264,000![]() (New Position) | View |
2023-01-04 08:10 am Purchase | 13G | Bone Biologics Corporation BBLG | SABBY MANAGEMENT LLC | 1,237,205 11% | 1,237,205![]() (New Position) | View |